Spiber

About:

Spiber is a biotech company that utilizes microbial fermentation technology to develop Brewed Protein from plant-based sugars.

Website: https://spiber.inc/en

Top Investors: The Carlyle Group, Fidelity International, MUFG Bank, JAFCO, Archer Daniels Midland Company

Description:

Established in September 2007, Spiber Inc. is a Japanese biotechnology startup utilizing cutting-edge synthetic biology, polymer, and material science for the development of its novel Brewed Protein™ materials. Produced through microbial fermentation and utilizing agricultural feedstocks as primary raw materials, Brewed Protein™ polymers are well-positioned to significantly contribute to animal- and plastic-free initiatives in various fields such as the apparel and automotive industries. Leveraging its R&D expertise, Spiber pursues its mission of positively contributing to sustainable human well-being. Operation of Spiber’s first mass production plant in Rayong Province, Thailand, is slated to commence within 2021. The company is also constructing a second mass production facility with partner ADM in Iowa, USA, which is scheduled to begin operating in 2023 at the earliest.